Ubs Group Ag Dermata Therapeutics Inc Wt Ex Transaction History
Ubs Group Ag
- $400 Billion
- Q2 2024
A detailed history of Ubs Group Ag transactions in Dermata Therapeutics Inc Wt Ex stock. As of the latest transaction made, Ubs Group Ag holds 5,042 shares of DRMAW stock, worth $50. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,042
Previous 1,485
239.53%
Holding current value
$50
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding DRMAW
# of Institutions
5Shares Held
192KCall Options Held
0Put Options Held
0-
Empery Asset Management, LP New York, NY175KShares$1,7500.1% of portfolio
-
Boothbay Fund Management, LLC New York, NY12KShares$1200.0% of portfolio
-
Bank Of America Corp Charlotte, NC200Shares$20.0% of portfolio
-
Concourse Financial Group Securities, Inc. Birmingham, AL0Shares$00.0% of portfolio
About DERMATA THERAPEUTICS INC WT EX
- Ticker DRMAW
- Sector Healthcare
- Industry Biotechnology